SK282567B6 - Orálny farmaceutický prostriedok proti kašľu - Google Patents
Orálny farmaceutický prostriedok proti kašľu Download PDFInfo
- Publication number
- SK282567B6 SK282567B6 SK1085-96A SK108596A SK282567B6 SK 282567 B6 SK282567 B6 SK 282567B6 SK 108596 A SK108596 A SK 108596A SK 282567 B6 SK282567 B6 SK 282567B6
- Authority
- SK
- Slovakia
- Prior art keywords
- benzydamine
- parts
- composition
- pharmaceutically acceptable
- hydrobromide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI940362A IT1274026B (it) | 1994-03-01 | 1994-03-01 | Composizione antitosse |
| PCT/EP1995/000658 WO1995023602A1 (en) | 1994-03-01 | 1995-02-22 | Antitussive composition containing an antitussive and benzydamine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK108596A3 SK108596A3 (en) | 1997-04-09 |
| SK282567B6 true SK282567B6 (sk) | 2002-10-08 |
Family
ID=11368015
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK1085-96A SK282567B6 (sk) | 1994-03-01 | 1995-02-22 | Orálny farmaceutický prostriedok proti kašľu |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5932589A (cs) |
| EP (1) | EP0748222B1 (cs) |
| JP (1) | JP3348858B2 (cs) |
| KR (1) | KR970701047A (cs) |
| CN (1) | CN1088358C (cs) |
| AT (1) | ATE195074T1 (cs) |
| AU (1) | AU681257B2 (cs) |
| BR (1) | BR9506956A (cs) |
| CA (1) | CA2184594C (cs) |
| CZ (1) | CZ284798B6 (cs) |
| DE (1) | DE69518229T2 (cs) |
| DK (1) | DK0748222T3 (cs) |
| ES (1) | ES2149969T3 (cs) |
| FI (1) | FI963394L (cs) |
| GR (1) | GR3034665T3 (cs) |
| HU (1) | HUT75937A (cs) |
| IT (1) | IT1274026B (cs) |
| NO (1) | NO309965B1 (cs) |
| NZ (1) | NZ281230A (cs) |
| PL (1) | PL178608B1 (cs) |
| PT (1) | PT748222E (cs) |
| RO (1) | RO117147B1 (cs) |
| RU (1) | RU2143901C1 (cs) |
| SK (1) | SK282567B6 (cs) |
| UA (1) | UA37278C2 (cs) |
| WO (1) | WO1995023602A1 (cs) |
| ZA (1) | ZA951588B (cs) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6124282A (en) * | 1997-05-22 | 2000-09-26 | Sellers; Edward M. | Drug formulations |
| DE69834268T2 (de) * | 1997-12-22 | 2007-04-12 | Euro-Celtique S.A. | Peroral zu verabreichende Arzneiform enthaltend eine Kombination von einem Opioid Agonisten und Naltrexon |
| AU784112B2 (en) * | 1999-04-06 | 2006-02-09 | Wm. Wrigley Jr. Company | Pharmaceutical chewing gum formulations |
| US7138133B2 (en) | 2001-10-10 | 2006-11-21 | The Procter & Gamble Company | Orally administered liquid compositions |
| WO2003089007A1 (en) * | 2002-04-22 | 2003-10-30 | Adcock Ingram Intellectual Property (Proprietary) Limited | Pharmaceutical compositions comprising a decongenstant and further active ingredients for treating cough and flu |
| EP1845942B1 (en) * | 2005-01-14 | 2014-04-09 | Camurus Ab | Gnrh analogue formulations |
| ES2400034T3 (es) * | 2005-01-14 | 2013-04-05 | Camurus Ab | Formulaciones bioadhesivas tópicas |
| CN101219140B (zh) * | 2007-12-24 | 2011-06-01 | 重庆市莱美药物技术有限公司 | 盐酸苄达明可溶片及其制备方法 |
| GEP20146156B (en) | 2009-07-08 | 2014-09-10 | Aziende Chimiche Riunite Angelini Francesco A C R A F S P A It | Benzydamine usage at p40-dependent diseases treatment |
| EP2968151B1 (en) * | 2013-03-13 | 2017-04-19 | Tris Pharma, Inc. | Benzonatate modified release solid tablets and capsules |
| JP6698669B2 (ja) * | 2015-02-09 | 2020-05-27 | セリックス バイオ プライヴェート リミテッドＣｅｌｌｉｘ Ｂｉｏ Ｐｒｉｖａｔｅ Ｌｉｍｉｔｅｄ | 粘膜炎の治療のための組成物及び方法 |
| WO2018191477A1 (en) * | 2017-04-14 | 2018-10-18 | Kempharm, Inc. | Dextrorphan prodrugs and processes for making and using them |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1054833A (cs) * | 1963-08-09 | |||
| US5196436A (en) * | 1990-10-31 | 1993-03-23 | The Procter & Gamble Company | Dextromethorphan antitussive compositions |
| FI931934A7 (fi) * | 1990-10-31 | 1993-05-31 | Procter & Gamble | Dekstrometorfaania sisältäviä yskänlääkekoostumuksia |
-
1994
- 1994-03-01 IT ITMI940362A patent/IT1274026B/it active IP Right Grant
-
1995
- 1995-02-22 AT AT95909772T patent/ATE195074T1/de not_active IP Right Cessation
- 1995-02-22 CZ CZ962532A patent/CZ284798B6/cs not_active IP Right Cessation
- 1995-02-22 JP JP52267395A patent/JP3348858B2/ja not_active Expired - Fee Related
- 1995-02-22 WO PCT/EP1995/000658 patent/WO1995023602A1/en active IP Right Grant
- 1995-02-22 NZ NZ281230A patent/NZ281230A/en not_active IP Right Cessation
- 1995-02-22 FI FI963394A patent/FI963394L/fi not_active Application Discontinuation
- 1995-02-22 RU RU96120415A patent/RU2143901C1/ru not_active IP Right Cessation
- 1995-02-22 US US08/700,362 patent/US5932589A/en not_active Expired - Fee Related
- 1995-02-22 UA UA96093730A patent/UA37278C2/uk unknown
- 1995-02-22 EP EP95909772A patent/EP0748222B1/en not_active Expired - Lifetime
- 1995-02-22 PT PT95909772T patent/PT748222E/pt unknown
- 1995-02-22 ES ES95909772T patent/ES2149969T3/es not_active Expired - Lifetime
- 1995-02-22 CA CA002184594A patent/CA2184594C/en not_active Expired - Fee Related
- 1995-02-22 AU AU18116/95A patent/AU681257B2/en not_active Ceased
- 1995-02-22 SK SK1085-96A patent/SK282567B6/sk unknown
- 1995-02-22 PL PL95316079A patent/PL178608B1/pl not_active IP Right Cessation
- 1995-02-22 BR BR9506956A patent/BR9506956A/pt not_active IP Right Cessation
- 1995-02-22 DK DK95909772T patent/DK0748222T3/da active
- 1995-02-22 HU HU9602390A patent/HUT75937A/hu unknown
- 1995-02-22 KR KR1019960704800A patent/KR970701047A/ko not_active Ceased
- 1995-02-22 RO RO96-01736A patent/RO117147B1/ro unknown
- 1995-02-22 DE DE69518229T patent/DE69518229T2/de not_active Expired - Fee Related
- 1995-02-22 CN CN95191917A patent/CN1088358C/zh not_active Expired - Fee Related
- 1995-02-24 ZA ZA951588A patent/ZA951588B/xx unknown
-
1996
- 1996-08-30 NO NO963634A patent/NO309965B1/no not_active IP Right Cessation
-
2000
- 2000-10-23 GR GR20000402355T patent/GR3034665T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5196436A (en) | Dextromethorphan antitussive compositions | |
| SG175979A1 (en) | Sublingual dexmedetomidine compositions and methods of use thereof | |
| US5741805A (en) | Controlled release pilocarpine delivery system | |
| SK282567B6 (sk) | Orálny farmaceutický prostriedok proti kašľu | |
| US6521266B1 (en) | Composition for growth hormone production and release, appetite suppression, and methods related thereto | |
| CA2386547C (en) | Orally disintegrating composition comprising mirtazapine | |
| US4892877A (en) | Antitussive liquid compositions containing phenol | |
| RU96120415A (ru) | Противокашлевая композиция, содержащая противокашлевое средство и бензидамин | |
| US5414005A (en) | Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation | |
| CA2129676C (en) | Dextromethorphan antitussive compositions | |
| CA2010022C (en) | Anesthetic oral compositions | |
| MXPA96003747A (en) | Antitus composition | |
| HK1168302A (en) | Sublingual dexmedetomidine compositions and methods of use thereof |